182 related articles for article (PubMed ID: 27959409)
1. Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension.
Hao M; Li M; Li W
Mol Med Rep; 2017 Jan; 15(1):160-168. PubMed ID: 27959409
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cells protect against hypoxia-induced pulmonary arterial hypertension in mice.
Chu Y; Xiangli X; Xiao W
Mol Med Rep; 2015 Apr; 11(4):3181-7. PubMed ID: 25523119
[TBL] [Abstract][Full Text] [Related]
3. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
Huh JW; Kim SY; Lee JH; Lee YS
Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
[TBL] [Abstract][Full Text] [Related]
4. Arginase inhibition protects against hypoxia‑induced pulmonary arterial hypertension.
Jiang W; Sun B; Song X; Zheng Y; Wang L; Wang T; Liu S
Mol Med Rep; 2015 Sep; 12(3):4743-4749. PubMed ID: 26126810
[TBL] [Abstract][Full Text] [Related]
5. [Effects of docosahexaenoic acid on hypoxia-induced pulmonary arterial hypertension].
Chen R; Liu P; Yan J; Gu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Feb; 37(2):109-12. PubMed ID: 24796591
[TBL] [Abstract][Full Text] [Related]
6. Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia.
Chu Y; XiangLi X; Niu H; Wang H; Jia P; Gong W; Wu D; Qin W; Xing C
Mol Cell Biochem; 2016 Jan; 412(1-2):91-9. PubMed ID: 26608181
[TBL] [Abstract][Full Text] [Related]
7. STARS knockout attenuates hypoxia-induced pulmonary arterial hypertension by suppressing pulmonary arterial smooth muscle cell proliferation.
Shi Z; Wu H; Luo J; Sun X
Biomed Pharmacother; 2017 Mar; 87():397-404. PubMed ID: 28068629
[TBL] [Abstract][Full Text] [Related]
8. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway.
He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J
Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells.
Xia S; Tai X; Wang Y; An X; Qian G; Dong J; Wang X; Sha B; Wang D; Murthi P; Kalionis B; Wang X; Bai C
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):66-73. PubMed ID: 20160044
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑30a‑5p promotes proliferation and inhibits apoptosis of human pulmonary artery endothelial cells under hypoxia by targeting YKL‑40.
Tan H; Yao H; Lie Z; Chen G; Lin S; Zhang Y
Mol Med Rep; 2019 Jul; 20(1):236-244. PubMed ID: 31115541
[TBL] [Abstract][Full Text] [Related]
11. Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice.
Shimizu T; Fukumoto Y; Tanaka S; Satoh K; Ikeda S; Shimokawa H
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2780-91. PubMed ID: 24135024
[TBL] [Abstract][Full Text] [Related]
12. miR‑760 mediates hypoxia-induced proliferation and apoptosis of human pulmonary artery smooth muscle cells via targeting TLR4.
Yang YZ; Zhang YF; Yang L; Xu J; Mo XM; Peng W
Int J Mol Med; 2018 Nov; 42(5):2437-2446. PubMed ID: 30226538
[TBL] [Abstract][Full Text] [Related]
13. miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling.
Liu T; Zou XZ; Huang N; Ge XY; Yao MZ; Liu H; Zhang Z; Hu CP
Life Sci; 2019 Jun; 227():64-73. PubMed ID: 31004656
[TBL] [Abstract][Full Text] [Related]
14. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
[TBL] [Abstract][Full Text] [Related]
15. [Effects of early digoxin treatment on hypoxia-induced pulmonary artery hypertension].
Yan G; Hu S; Wang Q; Wang D; Wang J; Qiao Y; Tang C; Ma G; Gu Y
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):139-43. PubMed ID: 24721356
[TBL] [Abstract][Full Text] [Related]
16. MKP-1 is a target of miR-210 and mediate the negative regulation of miR-210 inhibitor on hypoxic hPASMC proliferation.
Jin Y; Pang T; Nelin LD; Wang W; Wang Y; Yan J; Zhao C
Cell Biol Int; 2015 Jan; 39(1):113-20. PubMed ID: 25044272
[TBL] [Abstract][Full Text] [Related]
17. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
18. Leptin signalling system as a target for pulmonary arterial hypertension therapy.
Huertas A; Tu L; Thuillet R; Le Hiress M; Phan C; Ricard N; Nadaud S; Fadel E; Humbert M; Guignabert C
Eur Respir J; 2015 Apr; 45(4):1066-80. PubMed ID: 25745038
[TBL] [Abstract][Full Text] [Related]
19. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
[TBL] [Abstract][Full Text] [Related]
20. [Effect of opening of mitochondrial ATP-sensitive K⁺ channel on the distribution of cytochrome C and on proliferation of human pulmonary arterial smooth muscle cells in hypoxia].
Hu HL; Zhang ZX; Zhao JP; Wang T; Xu YJ
Sheng Li Xue Bao; 2006 Jun; 58(3):262-8. PubMed ID: 16786111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
